Immunotherapy advances in cancers with mismatch repair or proofreading deficiencies
Nat Cancer
.
2022 Dec;3(12):1414-1417.
doi: 10.1038/s43018-022-00497-5.
Authors
Emily Alouani
1
,
Benoit Rousseau
2
,
Thierry Andre
3
,
Aurelien Marabelle
4
Affiliations
1
Digestive Medical Oncology Department, IUCT-Rangueil, Toulouse Hospital University, Toulouse, France.
2
Department of Medicine, Division of Solid Tumors, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
3
Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, INSERM 938, SIRIC CURAMUS, Paris, France.
4
Université Paris Saclay, Gustave Roussy, Departement d'Innovation Therapeutique et d'Essais Precoces (DITEP), INSERM U1015 & CIC1428, Villejuif, France.
[email protected]
.
PMID:
36539500
DOI:
10.1038/s43018-022-00497-5
No abstract available
MeSH terms
DNA Mismatch Repair* / genetics
DNA Repair
DNA Replication
Humans
Immunotherapy / adverse effects
Neoplasms* / genetics
Neoplasms* / therapy